Pharmacy Articles

Pharmacy

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Carlson JJ et al. - The results of study suggest that compared with liver biopsy, non-invasive testing algorithms can result in short-term cost savings, but the consequences of misdiagnosis in terms of health outcomes and treatment costs might outweigh the short-term gains in cost and convenience.

Related Articles

Liver fibrosis in patients with chronic hepatitis C and persistently normal liver enzymes: influence of HIV infection
Journal of Viral Hepatitis, 10/13/09    Relevance Score: 69%

Monocytes and Macrophages as Cellular Targets in Liver Fibrosis
Inflammation & Allergy - Drug Targets, 10/09/09    Relevance Score: 69%

Antifibrotic effects of green tea on in vitro and in vivo models of liver fibrosis
World Journal of Gastroenterology, 11/12/09    Relevance Score: 68%

Genetic Risk Factor for Liver Disease for Patients With Cystic Fibrosis
Gastroenterology, 10/27/09    Relevance Score: 68%

Epithelial-to-mesenchymal transitions in the liver
Hepatology, 10/14/09    Relevance Score: 67%

Today in Pharmacoeconomics...keeping you current

Cost-effectiveness of single agent, uptitration and switching statin treatment strategies for lipid lowering in Sweden
Current Medical Research and Opinion, 12/14/09

Hospital visits and costs following outpatient treatment of CAP with levofloxacin or moxifloxacin
Current Medical Research and Opinion, 12/11/09

Economic consequences of ACS-related rehospitalizations in the US
Current Medical Research and Opinion, 12/10/09


Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Sponsor

Send this Summary to a Colleague

Enter email address